Encompass Health Corporation $EHC Shares Purchased by Intech Investment Management LLC

Intech Investment Management LLC raised its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 21.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,329 shares of the company’s stock after purchasing an additional 3,815 shares during the quarter. Intech Investment Management LLC’s holdings in Encompass Health were worth $2,160,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of EHC. WPG Advisers LLC bought a new position in Encompass Health during the 1st quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after buying an additional 367 shares during the last quarter. Arlington Trust Co LLC lifted its holdings in Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock worth $68,000 after buying an additional 125 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after buying an additional 115 shares during the last quarter. Finally, SVB Wealth LLC bought a new position in Encompass Health during the 1st quarter worth approximately $84,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Down 1.1%

Shares of EHC stock opened at $124.62 on Tuesday. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $127.15. The stock has a market cap of $12.55 billion, a PE ratio of 24.39, a price-to-earnings-growth ratio of 2.20 and a beta of 0.92. The business’s fifty day moving average is $117.61 and its 200-day moving average is $113.11. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.20 by $0.20. The business had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company’s quarterly revenue was up 12.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Wednesday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.17. Encompass Health’s payout ratio is presently 13.31%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. UBS Group increased their target price on Encompass Health from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Bank of America increased their target price on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. KeyCorp raised their price target on Encompass Health from $122.00 to $135.00 and gave the stock an “overweight” rating in a report on Tuesday, May 27th. Wall Street Zen downgraded Encompass Health from a “strong-buy” rating to a “buy” rating in a report on Friday, June 6th. Finally, Stephens raised Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price target on the stock in a report on Thursday, June 5th. One analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $137.71.

Insider Activity

In related news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.10% of the stock is owned by insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.